Detalhe da pesquisa
1.
Safety and immunogenicity of the tetravalent, live-attenuated dengue vaccine Butantan-DV in adults in Brazil: a two-step, double-blind, randomised placebo-controlled phase 2 trial
Lancet Infect. Dis.;
2020.
Artigo
em Inglês
| SES-SP, SESSP-IBPROD, SES-SP | ID: but-ib17572
2.
Safety and immunogenicity of the tetravalent, live-attenuated dengue vaccine Butantan-DV in adults in Brazil: a two-step, double-blind, randomised placebo-controlled phase 2 trial
Lancet Infect Dis, v. 20, n. 7, p. 839-850, mar. 2020
Artigo
em Inglês
| SES-SP, SESSP-IBPROD, SES-SP | ID: bud-2991
3.
ZikaPLAN: addressing the knowledge gaps and working towards a research preparedness network in the Americas
Global health action, v. 12, n. 1, p. 1666566, oct. 2019
Artigo
em Inglês
| SES-SP, SESSP-IBPROD, SES-SP | ID: bud-2866
4.
ZikaPLAN: addressing the knowledge gaps and working towards a research preparedness network in the Americas
Global health action;
12(1): 1666566, 2019.
Artigo
em Inglês
| SES-SP, SESSP-IBPROD, SES-SP | ID: but-ib17261